Toggle light / dark theme

#nutrition #CrapScience

So after 40 years of prescribing low fat diets & demonising cholesterol, the largest & longest clinical experiment ever (40 years, 9,000 patients, randomly assigned diets) shows that “Patients who lowered their cholesterol, presumably because of the special diet, actually suffered MORE heart-related deaths than those who did not.”

In other words, if you’ve been cutting on steaks, butter etc. for 4 years or more, you may have INCREASED your mortality rate from heart disease by %8.

Oops?

Via Oxford Martin School @oxmartinschool

Cover-fig-512x461

“DNA base pairing has been used for many years to direct the arrangement of inorganic nanocrystals into small groupings and arrays with tailored optical and electrical properties. The control of DNA-mediated assembly depends crucially on a better understanding of three-dimensional structure of DNA-nanocrystal-hybridized building blocks. Existing techniques do not allow for structural determination of these flexible and heterogeneous samples.”

Read more

My own prediction is that we will see singularity with humans 1st via BMI/ BI technology and other bio-computing technology before we see a machine brain operating a the level of a healthy fully funtional human brain.


Since War of the Worlds hit the silver screen, never has the notion that machine intelligence will overtake human intelligence is more real. In this two-part series, the author examines the growing trend towards cognitive machines.

Read more

It might be time to rethink fertility treatment.

Here’s the scoop: scientists at Northwestern University 3D printed a functional ovary out of Jello-like material and living cells. When implanted into mice that had their ovaries removed, the moms regained their monthly cycle and gave birth to healthy pups.

The scientists presented their results last week at the Endocrine Society’s annual meeting in Boston.

Read more

A major concerned for Lockheed is the long passage of time between the crew’s training and the moment a serious issue does come up during a mission—which could be a few years later. “They may not remember the training. Having the right kind of on-board documentation and flight computer to be able to provide the astronauts the information they need when they need it, is important,” Pratt said. “Not just having the alarm go off but having the alarm go off and the PDF file of the manual come up at the same time. That’s really useful in helping the crew understand how to operate their own vehicle.”

Even though Lockheed Martin’s early habitat concept will service exploration missions near the Moon, the company is always thinking about the manned mission to Mars, which will require a far more advanced successor to their current designs. Engineers will need to go through a few iterations of the concept after the health effects of long-duration human spaceflight are known and as new technology is developed. This is the basis that NASA created NextSTEP on.

The federal space agency is looking for a modular habitat that can grow, evolve and be added to. “New modules are built upon the lessons of the previous modules,” Hopkins said.

Read more

Very cool.


For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body. Tiny capsules, called nanoparticles, are now being used to transport chemotherapy medicine through the bloodstream, to the doorstep of cancerous tumors. But figuring out the best way for the particles to get past the tumor’s “velvet rope” and enter the tumor is a challenge scientists are still working out. Drexel University researchers believe that the trick to gaining access to the pernicious cellular masses is to give the nanoparticles a new look—and that dressing to impress will be able to get them past the tumor’s biological bouncers.

Targeted cancer therapy is most effective when the medication is released as close as possible to the interior of a , to increase its odds of penetrating and killing off cancerous cells. The challenge that has faced cancer researchers for years is making a delivery vehicle that is sturdy enough to safely get the medication through the bloodstream to tumors—which is no smooth ride—but is also lithe enough to squeeze through the tumor’s dense extra cellular space—a matrix stuffed with sugars called hyaluronic acid.

In research recently published in the journal Nano Letters, lead author Hao Cheng, PhD, an assistant professor with an appointment in Drexel’s College of Engineering, and affiliation with School of Biomedical Engineering, Science and Health Systems; reports that the way to get past the tumor’s front door has everything to do with how the tiny particle is suited up for the journey.

Read more

Nanomedicine has been something that many in tech expected to be a critical part of the healthcare landscape for over a decade. I am glad to see how quickly the technology is being adopted as part of bio-medical research and treatments for various diseases, etc.


NEW YORK, April 7, 2016 /PRNewswire/ — Nano-based science paving the precision medicine era.

The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics, diagnostics, theranostics, medical imaging, regenerative medicine, life sciences research and biosciences, among many others. In fact, nanomedicine is present in all therapeutic areas, exhibiting a perceptible and extensive impact in the treatment and diagnosis of some most concerned diseases.

Read more

Zika. Ebola. Dengue. Influenza. Chikungunya. These are but a few among the growing cadre of viruses that today pose serious health threats to U.S. troops, as well as to civilian populations in the United States and around the world. Vaccines exist for but a few of these infectious diseases. And since these viruses have an uncanny ability to mutate and morph as they reproduce inside their hosts, those few vaccines that do exist are quickly outdated, providing little protection against the latest viral strains. That’s why flu vaccine manufacturers, for example, must produce new versions annually, at enormous expense and with variable year-to-year efficacy.

Ideally, to outpace evolving pathogens, a therapy or a vaccine would adapt in real time, shape-shifting as fast as its targets do. To pursue that radical approach, DARPA today launched its INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program.

“We need a new paradigm to stay ahead of these moving targets,” said Jim Gimlett, DARPA program manager. “With INTERCEPT, the goal is to develop viral therapies that are effective against a broad spectrum of viral strains, and that can co-evolve and outpace new strains.”

Read more